(1) Focusing on tumor treatment: investigation of the mechanisms and optimal timing of combining PDT and ICIs is under way, and exploration of the impact of PDT regulating EGFR expression in lung cancer through the HIF-1 pathway on targeted therapy also holds promise [32]. This evidence concerns the gene HIF1A and lung carcinoma.